TY  - GEN
AU  - Knox,S J
AU  - Goris,M L
AU  - Tempero,M
AU  - Weiden,P L
AU  - Gentner,L
AU  - Breitz,H
AU  - Adams,G P
AU  - Axworthy,D
AU  - Gaffigan,S
AU  - Bryan,K
AU  - Fisher,D R
AU  - Colcher,D
AU  - Horak,I D
AU  - Weiner,L M
TI  - Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer
SN  - 1078-0432
PY  - 2000///0328
KW  - Adult
KW  - Aged
KW  - Anemia
KW  - etiology
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Biotin
KW  - administration & dosage
KW  - Colonic Neoplasms
KW  - pathology
KW  - Female
KW  - Humans
KW  - Leukopenia
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Organometallic Compounds
KW  - Radioimmunotherapy
KW  - Radiopharmaceuticals
KW  - Thrombocytopenia
KW  - Yttrium Radioisotopes
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
ER  -